• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Immunogenicity,effectiveness,and safety of COVID-19 vaccines among children and adolescents aged 2-18 years:an updated systematic review and meta-analysis

摘要Background During the coronavirus disease 2019(COVID-19)pandemic,there is an urgent need for safe and effective COVID-19 vaccines to protect children and adolescents.This study aims to provide scientific evidence and recommendations for the application of COVID-19 vaccines in children and adolescents by analyzing the latest studies.Methods We systematically searched MEDLINE(accessed through PubMed),Embase,and Web of Science from January 1,2020,to October 8,2022.Eligible clinical trials,cohort studies,case-control studies,and cross-sectional studies with extractable data were included in immunogenicity,effectiveness,and safety analyses.According to the heterogeneity,we chose a fixed-effect model(when I2 ≤ 50)or a random-effects model(when I2>50)to pool effect values.Results A total of 88 articles were included.The seroconversion rates after the first,second,and third doses of the vac-cines were 86.10%,96.52%,and 99.87%,respectively.After the first and second doses,vaccine effectiveness(VE)against severe acute respiratory syndrome coronavirus 2 infection was 42.87%[95%confidence interval(CI)=27.09%-58.65%]and 63.33%(95%CI=52.09%-74.56%),respectively.After the first and second doses,VE against COVID-19 was 60.65%(95%CI=44.80%-76.50%)and 75.77%(95%CI=63.99%-87.56%),respectively.VE against hospitalization due to COVID-19 after the first and second doses was 72.74%(95%CI=51.48%-94.01%)and 82.78%(95%CI=75.78%-89.78%),respectively.The most common adverse events were injection site pain,fatigue/asthenia/tiredness,headache,myalgia/muscle pain,and chills.The incidence rate of myocarditis or pericarditis was 2.42/100,000 people.In addition,the subgroup analysis showed that children aged ≤ 5 years had the lowest incidence of adverse events,and the incidence rate of adverse events was higher for mRNA vaccines than for inactivated vaccines.Conclusions COVID-19 vaccines have good immunogenicity,effectiveness,and safety among children and adolescents.We recommend that children and adolescents be vaccinated as soon as possible to protect them and slow the spread of COVID-19.

更多
广告
作者 Peng Gao [1] Liang-Yu Kang [1] Jue Liu [2] Min Liu [1] 学术成果认领
作者单位 Department of Epidemiology and Biostatistics,School of Public Health,Peking University,No.38,Xueyuan Road,Haidian District,Beijing 100191,China [1] Department of Epidemiology and Biostatistics,School of Public Health,Peking University,No.38,Xueyuan Road,Haidian District,Beijing 100191,China;Institute for Global Health and Development,Peking University,No.5,Yiheyuan Road,Haidian District,Beijing 100871,China [2]
栏目名称 Meta-analyses
DOI 10.1007/s12519-022-00680-9
发布时间 2023-12-22
提交
  • 浏览3
  • 下载0
世界儿科杂志(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷